P
ProHub
English 简体中文 繁體中文
Medium Market Entry Pricing Competitive Dynamics

New Vaccine

#Healthcare #Pharmaceuticals
ProHub Comment

This is a quantitative market entry case requiring candidates to move beyond basic calculations toward strategic cost-benefit analysis. The key insight is recognizing that the vaccine is only cost-effective for certain baby weight segments, making selective market capture critical to viability.

Estimated Time 15 minutes
Difficulty Medium
Source Chicago Booth
50 / 100
Our client is a large pharmaceutical corporation, and they have developed a new vaccine that prevents low birth weight infants from contracting staph infections. They have approached us to determine the potential for this vaccine.

Clarifying Information

  1. When the candidate asks what is meant by the ‘potential for this vaccine,’ explain that our client is looking for clarity around revenue potential and a cost-benefit analysis of administering the vaccine.
  2. Our client is looking to launch this product in the United States, and is not currently concerned about international potential.